BusinessProQR Provides Enrollment Update on QR-110 Clinical Trial and Highlights Ophthalmology Presentations at ARVOBy Nasdaq OMXApr 23, 2018, 11:00 AM UTC
BusinessProQR to Present its Ophthalmology Pipeline at ARVO, Highlighting Programs in Leber’s Congenital Amaurosis Type 10 (LCA 10) and Usher SyndromeBy Nasdaq OMXMay 1, 2017, 11:01 AM UTC
BusinessProQR to Present its Ophthalmology Pipeline at ARVO, Highlighting Programs in Leber’s Congenital Amaurosis Type 10 (LCA 10) and Usher SyndromeBy Nasdaq OMXMay 1, 2017, 11:01 AM UTC
